PTC Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 272.6M | 164.7M | 211.0M | 178.9M | 1.18B | 213.2M | 196.8M | 186.7M |
| Cost of Goods Sold | 39.6M | 16.3M | 115.9M | 11.4M | 12.9M | 16.3M | 10.8M | 15.5M |
| Gross Profit | 232.9M | 148.4M | 95.1M | 167.5M | 1.16B | 196.9M | 185.9M | 171.2M |
| R&D Expenses | 100.9M | 133.1M | 100.2M | 113.0M | 109.0M | 124.8M | 161.4M | 132.2M |
| Operating Expenses | 187.1M | 230.0M | 92.1M | 202.4M | 193.0M | 359.3M | 240.4M | 211.4M |
| Operating Income | 45.9M | -81.6M | 3.0M | -35.0M | 970.2M | -162.4M | -54.5M | -40.2M |
| Other Income / Gains | -48.3M | -57.5M | -26.1M | -36.1M | -40.4M | 67.7M | -43.5M | -45.5M |
| Net Income | -2.8M | -135.0M | 15.9M | -64.8M | 866.6M | -65.9M | -106.7M | -99.2M |
| EPS (Diluted) | -0.034 | -1.67 | 0.20 | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.855 | 0.901 | 0.451 | 0.936 | 0.989 | 0.924 | 0.945 | 0.917 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 86.2M | 100.5M | 84.0M | 85.3M | 81.0M | 84.7M | 73.5M | 69.5M |
| Other Expenses | 0 | -3.6M | -92.2M | 4.2M | 3.1M | 149.8M | 5.6M | 9.7M |
| Cost And Expenses | 226.7M | 246.3M | 208.0M | 213.8M | 205.9M | 375.6M | 251.3M | 226.9M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -49.0M | 55.2M | 32.6M | 30.4M | 34.1M | 41.1M | 41.6M | 43.5M |
| Depreciation And Amortization | 15.4M | 12.9M | 11.1M | 7.6M | 7.2M | 6.8M | 6.5M | 7.0M |
| Ebitda | 61.3M | -71.0M | 20.6M | -33.1M | 971.1M | -46.9M | -49.9M | -35.2M |
| Ebitdaratio | 0.225 | -0.431 | 0.098 | -0.185 | 0.826 | -0.22 | -0.254 | -0.189 |
| Operating Income Ratio | 0.168 | -0.496 | 0.014 | -0.195 | 0.825 | -0.762 | -0.277 | -0.215 |
| Income Before Tax | -2.5M | -139.1M | -23.1M | -71.1M | 929.8M | -94.7M | -98.0M | -85.7M |
| Income Before Tax Ratio | -0.009 | -0.845 | -0.109 | -0.397 | 0.791 | -0.444 | -0.498 | -0.459 |
| Income Tax Expense | 347K | -4.1M | -39.0M | -6.2M | 63.3M | -28.8M | 8.7M | 13.4M |
| Net Income Ratio | -0.01 | -0.82 | 0.075 | -0.363 | 0.737 | -0.309 | -0.542 | -0.531 |
| Epsdiluted | -0.034 | -1.67 | 0.20 | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 |
| Weighted Average Shs Out | 82.5M | 80.7M | 81.5M | 78.2M | 78.1M | 77.2M | 76.9M | 76.7M |
| Weighted Average Shs Out Dil | 82.5M | 80.7M | 87.1M | 78.2M | 86.4M | 77.2M | 76.9M | 76.7M |